Two drugs have been licensed in the US and Europe for the treatment of advanced pancreatic NETs.
Afinitor is a medicine containing the active substance everolimus. Everolimus reduces the blood supply to the tumor and slows down the growth and spread of cancer cells. Afinitor is used to treat advanced neuroendocrine tumors that originate from the pancreas.
Sutent may slow or stop some cancers. It works by blocking 2 basic processes that cause tumors to grow and spread. These processes are called proliferation (cells dividing) and angiogenesis (growth of new blood vessels). Sutent is used to treat locally advanced or metastatic pancreatic neuroendocrine tumours where surgery is not possible.